Belgium- Environmental releases

Back to the list      Previous Record      Next Record

EU identification numberB/BE/00/V15
Year of release2000
Title of projectDevelopment of a combined vaccine against equineinfluenza and tetanus. Experiment outside containment (clinical trial)for the study of the safety and efficacy of an intramuscular administrationof recombinant canarypoxvirus expressing equine influenza virus Haemagglutiningene.
Organism Common NameCanarypoxvirus
Organism Scientific NameCanarypoxvirus
TraitRMB715-20 vaccine
Total surfaceRelease site in horse stables or at the horseowner place under the responsability of 2 veterinarians.
Period of releaseDecember 2000 - December 2001
Number of sitesAbout 50 vaccinated horses will be includedin the trial.
LocationsGentbrugge, Bornem
Containment measuresTreatment of waste (bottles and sringes willbe recovered, then destroyed by incineration). The presence of emergencyresponse plans describing the methods and procedures for controlling GMO’sin case of unexpected spread, for decontamination of affected areas, forthe protection of human health and the environment in case of the occurenceof undesirable effect.
MonitoringAs described in the technical document.
Remarksto be determined
Type of procedureClassical procedure - Art. 9§1 of RoyalDecision
Advisory BodyBiosafety Advisory Council
Adviceto be determined
Competent AuthorityMinister of Public Health (General Inspectionof Pharmacy) and regional ministers of environment

Back to the list      Previous Record      Next Record
© Service of Biosafety and Biotechnology